In 1989, the MMPI became the MMPI-2 as a result of a restandardization project to develop a new set of normative data representing current population characteristics the restandardization increased the size of the normative database to include a wide range of clinical and non-clinical samples psychometric characteristics of the Clinical Scales were not addressed at that time.
![mmpi 2 purpose mmpi 2 purpose](https://i.ytimg.com/vi/Pj5PyXca8SE/maxresdefault.jpg)
The most historically significant developmental changes include: Additionally, there have been changes in the number of items in the measure, and other adjustments which reflect its current use as a tool towards modern psychopathy and personality disorders. Many additions and changes to the measure have been made over time to improve interpretability of the original Clinical Scales. The MMPI was designed as an adult measure of psychopathology and personality structure in 1939. The MMPI is copyrighted by the University of Minnesota. The original authors of the MMPI were Starke R. An alternative version of the test, the MMPI-2 Restructured Form (MMPI-2-RF), published in 2008, retains some aspects of the traditional MMPI assessment strategy, but adopts a different theoretical approach to personality test development. A version for adolescents, the MMPI-A, was published in 1992. It was replaced by an updated version, the MMPI-2, in 1989 (Butcher, Dahlstrom, Graham, Tellegen, and Kraemmer). McKinley, faculty of the University of Minnesota, and first published by the University of Minnesota Press in 1943. The original MMPI was developed by Starke R. Psychologists and other mental health professionals use various versions of the MMPI to help develop treatment plans assist with differential diagnosis help answer legal questions (forensic psychology) screen job candidates during the personnel selection process or as part of a therapeutic assessment procedure.
![mmpi 2 purpose mmpi 2 purpose](https://www.parinc.com/Portals/0/Product/UploadFiles/Images/MMPI-2_STSUM.gif)
The clinical implications of these preliminary findings are discussed.The Minnesota Multiphasic Personality Inventory (MMPI) is a standardized psychometric test of adult personality and psychopathology. Overall, these preliminary findings suggest that Rorschach indices are promising psychometric markers for depression and psychotic disorders. The MCMI-II did not detect psychosis at a rate above chance and frequently inaccurately classified psychotic patients as nonpsychotic. Second, the Rorschach was more sensitive and specific to psychotic disorders than either the MMPI or MCMI-II. The Rorschach has a lower rate of false positives and higher specificity than the MMPI and the MCMI-II. However, high MMPI and MCMI-II scores are not specific to depression and misclassify a substantial percentage of nondepressed patients as being depressed. First, the MMPI, MCMI-II, and Rorschach are comparable in their sensitivity to detecting depression. Although only limited conclusions can be reached because of the small number of existing studies and methodological problems, several preliminary observations were made. The methodological limitations of these studies are identified and suggestions for improving future research are offered.
![mmpi 2 purpose mmpi 2 purpose](https://medcraveonline.com/FRCIJ/images/FRCIJ-06-00209-g002.png)
Studies examining the diagnostic performance of these measures published in the Journal of Clinical and Consulting Psychology, Psychological Assessment, and the Journal of Personality Assessment were included in this review. The diagnostic efficiency of the Minnesota Multiphasic Personality Inventory (MMPI), Millon Clinical Multiaxial Inventory-II (MCMI-II), and Rorschach Comprehensive System for detecting depressive and psychotic disorders were compared.